171 related articles for article (PubMed ID: 37713832)
1. Comprehensive analysis of the oncogenic and immunological role of SPON2 in human tumors.
Tang J; Huang Q; Li X; Gu S
Medicine (Baltimore); 2023 Sep; 102(37):e35122. PubMed ID: 37713832
[TBL] [Abstract][Full Text] [Related]
2. Tumor cell-derived SPON2 promotes M2-polarized tumor-associated macrophage infiltration and cancer progression by activating PYK2 in CRC.
Huang C; Ou R; Chen X; Zhang Y; Li J; Liang Y; Zhu X; Liu L; Li M; Lin D; Qiu J; Liu G; Zhang L; Wu Y; Tang H; Liu Y; Liang L; Ding Y; Liao W
J Exp Clin Cancer Res; 2021 Sep; 40(1):304. PubMed ID: 34583750
[TBL] [Abstract][Full Text] [Related]
3. GPC2 Is a Potential Diagnostic, Immunological, and Prognostic Biomarker in Pan-Cancer.
Chen G; Luo D; Zhong N; Li D; Zheng J; Liao H; Li Z; Lin X; Chen Q; Zhang C; Lu Y; Chan YT; Ren Q; Wang N; Feng Y
Front Immunol; 2022; 13():857308. PubMed ID: 35345673
[TBL] [Abstract][Full Text] [Related]
4. SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival.
Schmid F; Wang Q; Huska MR; Andrade-Navarro MA; Lemm M; Fichtner I; Dahlmann M; Kobelt D; Walther W; Smith J; Schlag PM; Stein U
Oncogene; 2016 Nov; 35(46):5942-5952. PubMed ID: 26686083
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of Spondin-2 protein expression correlates with poor prognosis in hepatocellular carcinoma.
Feng Y; Hu Y; Mao Q; Guo Y; Liu Y; Xue W; Cheng S
J Int Med Res; 2019 Feb; 47(2):569-579. PubMed ID: 30318967
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of Spondin-2 Is Associated with Recurrence-Free Survival in Patients with Localized Clear Cell Renal Cell Carcinoma.
Ma HM; Yu M; Wu C; Huang HB; Li YW; Zhang P; Huang JJ; Cheng L; Feng G; Li GR
Dis Markers; 2020; 2020():5074239. PubMed ID: 32952742
[TBL] [Abstract][Full Text] [Related]
7. Spondin 2 promotes the proliferation, migration and invasion of gastric cancer cells.
Lu H; Feng Y; Hu Y; Guo Y; Liu Y; Mao Q; Xue W
J Cell Mol Med; 2020 Jan; 24(1):98-113. PubMed ID: 31691494
[TBL] [Abstract][Full Text] [Related]
8. The clinical significance of spondin 2 eccentric expression in peripheral blood mononuclear cells in bronchial asthma.
Zhou P; Xiang CX; Wei JF
J Clin Lab Anal; 2021 Jun; 35(6):e23764. PubMed ID: 33998076
[TBL] [Abstract][Full Text] [Related]
9. Cancer-associated Fibroblast-derived Spondin-2 Promotes Motility of Gastric Cancer Cells.
Kuramitsu S; Masuda T; Hu Q; Tobo T; Yashiro M; Fujii A; Kitagawa A; Abe T; Otsu H; Ito S; Oki E; Mori M; Mimori K
Cancer Genomics Proteomics; 2021; 18(4):521-529. PubMed ID: 34183385
[TBL] [Abstract][Full Text] [Related]
10. Spondin-2, a secreted extracellular matrix protein, is a novel diagnostic biomarker for prostate cancer.
Lucarelli G; Rutigliano M; Bettocchi C; Palazzo S; Vavallo A; Galleggiante V; Trabucco S; Di Clemente D; Selvaggi FP; Battaglia M; Ditonno P
J Urol; 2013 Dec; 190(6):2271-7. PubMed ID: 23665271
[TBL] [Abstract][Full Text] [Related]
11. The biological functions and related signaling pathways of SPON2.
Zhang J; Liu G; Liu Y; Yang P; Xie J; Wei X
Front Oncol; 2023; 13():1323744. PubMed ID: 38264743
[TBL] [Abstract][Full Text] [Related]
12. The MACC1-SPON2 axis: a new biomarker and therapeutic target in colorectal cancer.
Chandrasinghe P; Stebbing J; Warusavitarne J
Oncogene; 2017 Mar; 36(11):1474-1475. PubMed ID: 27669439
[TBL] [Abstract][Full Text] [Related]
13. ERH Impacts Patient Prognosis and Tumor Immune Microenvironment: A Pan-Cancer Analysis.
Gong Q; Li Q; Shen X; Xu Z
Comb Chem High Throughput Screen; 2024 Apr; ():. PubMed ID: 38584561
[TBL] [Abstract][Full Text] [Related]
14. Spondin-2 (SPON2), a more prostate-cancer-specific diagnostic biomarker.
Qian X; Li C; Pang B; Xue M; Wang J; Zhou J
PLoS One; 2012; 7(5):e37225. PubMed ID: 22615945
[TBL] [Abstract][Full Text] [Related]
15. Pan-cancer analysis reveals DDX21 as a potential biomarker for the prognosis of multiple tumor types.
Hu A; Wang Y; Tian J; Chen Z; Chen R; Han X; Chen Y; Liu T; Chen Q
Front Oncol; 2022; 12():947054. PubMed ID: 36505822
[TBL] [Abstract][Full Text] [Related]
16. Prognostic, Immunological, and Mutational Analysis of MTA2 in Pan-Cancer and Drug Screening for Hepatocellular Carcinoma.
Huang X; Tan J; Chen M; Zheng W; Zou S; Ye X; Li Y; Wu M
Biomolecules; 2023 May; 13(6):. PubMed ID: 37371463
[TBL] [Abstract][Full Text] [Related]
17. SPON2 promotes the bone metastasis of lung adenocarcinoma via activation of the NF-κB signaling pathway.
Wu M; Kong D; Zhang Y
Bone; 2023 Feb; 167():116630. PubMed ID: 36427776
[TBL] [Abstract][Full Text] [Related]
18. Pan-cancer analysis combined with experiments explores the oncogenic role of spindle apparatus coiled-coil protein 1 (SPDL1).
Song P; Wusiman D; Li F; Wu X; Guo L; Li W; Gao S; He J
Cancer Cell Int; 2022 Jan; 22(1):49. PubMed ID: 35093072
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of spondin-2 predicts poor survival of colorectal carcinoma patients.
Zhang Q; Wang XQ; Wang J; Cui SJ; Lou XM; Yan B; Qiao J; Jiang YH; Zhang LJ; Yang PY; Liu F
Oncotarget; 2015 Jun; 6(17):15095-110. PubMed ID: 25945835
[TBL] [Abstract][Full Text] [Related]
20. Structure-based design of competitive ligands to target Spon2 in gastric cancer: An integration of molecular modeling and in vitro assay.
Xu Z; Yu Z; Nai S; Shi R; Tang Q; Zhang H; Ye L; Wang L; Hong Y
Bioorg Chem; 2017 Oct; 74():115-121. PubMed ID: 28772159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
